Integrative Medicine > Antineoplastons


Gliomas

Buckner JC, Malkin MG, Reed E, Cascino TL, Reid JM, Ames MM, Tong WP, Lim S, Figg WD
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma
Mayo Clin Proc 1999 Feb;74(2):137-45 (Clinical Study, Abstract)

Burzynski SR
The present state of antineoplaston research (1)
Integr Cancer Ther. 2004 Mar;3(1):47-58. (Review Article, Abstract+)

 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP